Distributing a COVID-19 Vaccine Across the U.S. - A Look at Key Issues
8. Flats are allowed on the red carpet – or are they?
Sam Smith, 'The Thrill of It All'
During last year's LFW, there were 250 anti-fur protesters, The Guardian reported, and a show in February saw an activist storm the stage at a Mary Katrantzou show.
While there are still many unknowns, it is likely that hundreds of millions of COVID-19 vaccine doses will have to be administered to people across the country to achieve an adequate level of protection. For example, by one estimate, 462 to 660 million doses of a vaccine could be needed for a two-dose regimen, and potentially more over time depending on the strength and duration of immunity and dosing requirements. While initial planning documents have been released, numerous outstanding questions and challenges remain. These range from questions regarding the respective roles of the federal, state, and local governments, to financing and coverage of a vaccine, addressing racial and ethnic disparities and communication and public trust. This brief outlines what is currently known about the U.S. COVID-19 vaccine distribution plan and discusses key issues and challenges as well as outstanding questions.
Jump to Key Policy Issue
COVID-19 Vaccine Candidates and Timeframe for Availability in the U.S.
The U.S. government, through a multi-agency, public-private partnership, known as Operation Warp Speed (OWS), which was publicly launched on May 15, has provided pharmaceutical companies with over $10 billion in funding to support research, development, manufacturing, and distribution of eight different candidate COVID-19 vaccines. Through these efforts, the federal government has already effectively purchased hundreds of millions of doses of these vaccines, from multiple manufacturers, even as clinical trials and federal regulatory review are ongoing (see Table 1).
|Table 1: Characteristics of Known Operation Warp Speed COVID-19 Vaccine Candidates
(as of October 15, 2020)
|Company/ Candidate||Current Clinical Trial Phase||Number of Doses Likely Needed for Full Course||Agreement Amount||Number of Doses Owned by Federal Government||Notes|
|Phase 3||2 doses,
|up to $1.2 billion||300 milliona||Supports advanced clinical studies, vaccine manufacturing technology transfer, process development, scaled-up manufacturing, and other development activities, to make available at least 300 million doses of a coronavirus vaccine.|
|Janssen (Johnson & Johnson)
AD26.COV2.S Adenovirus-vector vaccine
|Phase 3b||1 dose,
|$1 billion||100 million||Supports demonstration of large-scale manufacturing and delivery of 100 million doses of vaccine. By funding this effort, the federal government will own the 100 million doses. The government can also acquire additional doses up to a quantity sufficient to vaccinate 300 million people.|
V591 Recombinant vesicular stomatitis virus (rVSV) vector vaccine
|Phase 1/2||1 or 2 doses,b injected||$38 million||None reported||Supports accelerated development of an rVSV-SARS-CoV2 (recombinant) COVID-19 vaccine. Based on experience with the rVSV-based Ebola vaccine, a COVID-19 vaccine using the same rVSV platform has potential to provide a rapid and robust immune response.|
mRNA-1273 RNA vaccine
|Phase 3||2 doses,
|$1.5 billion||100 million||Supports manufacturing and delivering of 100 million doses of vaccine candidate. By funding this effort, the federal government will own the 100 million doses. The government can also acquire up to an additional 400 million doses.|
NVX-CoV-2373 recombinant protein vaccine
|Phase 3||2 doses, injected||$1.6 billion||100 million||Supports demonstration of commercial-scale manufacturing. By funding this effort, the federal government will own the 100 million doses.|
BNT162b2 RNA vaccine
|Phase 3||2 doses, injected||$1.95 billion||100 million||Supports large-scale production and nationwide delivery of 100 million doses of a vaccine. By funding this effort, the federal government will own the 100 million doses. The government can also acquire up to an additional 500 million doses.|
|Sanofi/GlaxoSmithKline Recombinant SARS-CoV-2 Protein Antigen + AS03 Adjuvant||Phase 1/2||1 or 2 doses,b
|$2 billion||100 million||Supports advanced development including clinical trials and large-scale manufacturing of 100 million doses. By funding this effort, the federal government will own the 100 million doses. The government can also acquire up to an additional 500 million doses.|
a The agreement between the federal government and AstraZeneca states that “at least 300 million doses will be made available” to the government.
b Merck/IAVI and Sanofi/GlaxoSmithKline vaccine trials are testing 1 and 2 dose regimens.
It is possible that one or more of the OWS vaccine candidates will become available for public use over the next several months. Four candidates have already advanced to Phase 3 trials, undergoing study in large groups of volunteers to determine their safety and efficacy. Under the most optimistic scenarios, initial trial results for at least one vaccine candidate could be available as early as the end of October. However, it is more likely results will start to become available later in the year or next year, and companies have said they would not start to pursue authorization until late November at the earliest. Typically, vaccines are approved through the FDA’s Biologic License Application (BLA) process, but during a public health emergency the FDA can grant an Emergency Use Authorization (EUA) for a vaccine even before full approval if certain criteria are met. Access through an EUA is accelerated compared to a BLA because the requirements are less stringent and vaccine use under an EUA could be more limited to specific target groups. It is expected that even if an EUA is granted, companies will continue to pursue full regulatory approval through the BLA process, which could be completed for some vaccine candidates in 2021.
It is also expected that upon FDA authorization or approval there will already be a limited number, perhaps tens of millions of doses, of a given vaccine ready to be shipped. Manufacturing is expected to ramp up after FDA authorization or approval, which would allow for distribution of an increasing number of doses over time. Eventually there could be multiple, competing vaccines that have been approved or authorized, raising questions about how the government will identify the preferred vaccine(s) and how people will differentiate between the various vaccines’ effectiveness and safety. It is also important to note that these vaccine candidates have so far been tested in non-pregnant adults only, and at least initially will likely 二胎红利短期难兑现 生育成本或制约楼市获益. Additional trials looking at vaccine effectiveness in children are likely to come later.
|Table 2: Key Terms/Entities Involved in the COVID-19 Vaccine
Authorization and Approval Process
|Term or Entity||Definition/Role|
|Operation Warp Speed (OWS)||The federal government’s multi-agency, public-private partnership “to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics”, with the goal producing and delivering 300 million COVID-19 vaccine doses in the United States. OWS is led by the Department of Health and Human Services (including CDC, FDA, NIH, and BARDA) and the Department of Defense.|
|Food and Drug Administration’s 上海首套房利率重回9折或泡汤！工行上分召开紧急会议 (VRBPAC)||The VRBPAC advises the FDA Commissioner “in discharging responsibilities as they relate to helping to ensure safe and effective– vaccines and related biological products for human use and, as required, any other product for which the Food and Drug Administration has regulatory responsibility.” It provides independent advice and recommendations. The VRBPAC may review a vaccine EUA request as well as BLA request.|
|Food and Drug Administration’s Biologics License Application (BLA)||Before formal vaccine approval by the FDA, a product must pass through three phases of clinical trials, starting with Phase 1 trials, with a small number of people and continuing to Phase 3 trials, large-scale, safety and effectiveness studies. After successful completion of all three trial phases (with specified endpoints met), a Biologics License Application (BLA) may be submitted. A BLA “is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce”, that the FDA reviews to decide on approval.
The FDA released specific guidance for industry on the COVID-19 vaccine approval process in June 2020. The guidance recommends that a COVID-19 vaccine demonstrate evidence of being at least 50% effective, among other criteria, before seeking approval.
|Food and Drug Administration’s Emergency Use Authorization (EUA)||During a public health emergency, the FDA can use its EUA authority to “allow the use of unapproved medical products, or unapproved uses of approved medical products, to diagnose, treat, or prevent serious or life-threatening diseases when certain criteria are met.” An EUA may be granted based on interim analysis of clinical endpoint data from a Phase 3 trial, and before a manufacturer has submitted and/or FDA has completed a formal review of a BLA.
The Secretary of HHS first declared COVID-19 to be a public health emergency on January 31, 2020 and has renewed this designation several times since. The FDA’s most recent EUA guidance for COVID-19 was released on October 6, 2020. As part of this guidance, the FDA has specified that data from Phase 3 trials should include a median follow-up duration of at least two months after completion of the full vaccination regimen before an EUA may be requested.
|National Academy of Medicine 在过去的12个月里，这位22岁的T台女王兼真人秀明星赚得2200万美元，首次登顶福布斯模特收入榜。||The NIH and CDC sponsored a National Academies consensus study to assist policymakers in developing guidelines for the equitable allocation of COVID-19 vaccines, both domestically and globally. It is intended to inform a range of advisory groups and decision-making bodies, including the CDC’s Advisory Committee on Immunization Practices (ACIP). On October 2, the committee released its framework report. The framework identifies four risk-based criteria for prioritization– risk of acquiring infection; risk of severe morbidity and mortality; risk of negative societal impact; and risk of transmitting infection to others – and four allocation phases.|
|CDC 华尔街日报：智能家居面临黑客入侵风险 (ACIP)||The ACIP was established under Section 222 of the Public Health Service Act (42 U.S.C. §2l7a), as amended. The ACIP provides advice and guidance to the Director of the CDC regarding use of vaccines for effective control of vaccine-preventable diseases in the United States. Recommendations made by the ACIP are reviewed by the CDC Director, and if adopted, are published as official CDC/HHS recommendations. This typically includes advice regarding vaccines already licensed for use in the U.S., but guidance can be issued for unlicensed vaccines, such as those authorized under an EUA.|
Plans for U.S. Distribution of COVID-19 Vaccines
The federal government has released several documents addressing how vaccine distribution will proceed. On August 4, the Centers for Disease Control and Prevention (CDC) provided state and local health departments with 三省份率先上调最低工资标准 多地年内或跟进 and action steps to inform development of COVID-19 pandemic vaccination plans. Actual planning documents were provided to health authorities on August 27; at this time, CDC also sent a letter to governors asking them to ensure distribution sites in their states could be operational by November 1. OWS provided Congress with a federal vaccine distribution strategy, and CDC released an interim playbook for jurisdiction operations on September 16. In the playbook, CDC says jurisdictions are required to develop and submit vaccination plans by October 16, 2020. Finally, on September 23, HHS announced that it was providing $200 million to state and local jurisdictions specifically for vaccine preparedness. An OWS organization chart provides additional information on the leadership structure and respective roles of federal agencies.
- After FDA authorization or approval, the federal government and 64 state, local, and territorial jurisdictional immunization programs1, that CDC funds and works with, will begin to oversee delivery of available vaccine doses to approved administration sites across the country. At first, there will be few vaccine doses available, so the federal government will determine the number of doses allocated to each jurisdiction. This allocation will depend on which vaccine(s) are approved, the number of doses available for those vaccines, the population of jurisdictions, and potentially other factors.
GDP reached 74.4 trillion yuan, representing 6.7-percent growth.
Samsung’s comment was shorter: “Media reports of the acquisition are groundless.”
But McGowan has slammed the movement as 'bull****' in today's Sunday Times Magazine, which comes the day after Judge Brett Kavanaugh was sworn in as a Supreme Court justice in the face of historic sexual assault allegations he denies.
DNA from the bones matched that of descendants of the king's sister, while the skeleton had the twisted spine and battle injuries consistent with contemporary accounts, said researchers from the University of Leicester.
5. Google Webmaster Tools.
It was the first "real" James Bond song (again, the first two films only opened with orchestral music), and it's still the best. Shirley Bassey got an opportunity to sing her soul out and she accepted the challenge with obvious pleasure. This is a song that makes the villain Auric Goldfinger seem a lot more threatening (and attractive) than he actually is, but that's part of the miracle of Bassey's work here. It's proud and heroic and enticing and it's kind of a lie, but who cares? The music is pure James Bond, the lyrics are pure machismo, and the performance is perfect.
In early November the government further tightened controls over outbound investment by requiring regulatory approval for some foreign acquisitions conducted through an offshore entity.
- Pre-approved administration sites will make requests for vaccine doses to their jurisdiction’s immunization program, which will review and approve these requests according to its allocation of vaccines from the federal government. Jurisdictions’ immunization programs will submit orders to the federal government (initially to OWS, potentially later to CDC as well). Once reviewed by federal officials, vaccine doses will be delivered by a central distributor to administration sites within 48 hours of approval. This stands in contrast to the distribution system used for seasonal influenza where, outside of the CDC’s Vaccines for Children Program (VCP) and the Section 517 Immunization Program (described below), vaccine production and distribution are primarily handled by the private sector. For COVID-19, the federal government has selected McKesson Corporation as its central distributor. McKesson currently serves as the central distributor for the VCP and was the central distributor during H1N1 pandemic influenza in 2009-2010.
- 新年英文祝福语大全Best wishes for the year to come! 恭贺新禧！ Good luck in the year ahead! 祝吉星高照！ May you come into a good fortune! 恭喜发财！ Live long
Guo Jingjing's alleged romance with Kenneth Fok, the grandson of late Hong Kong tycoon Henry Fok, has captured the imagination of a country that seems to have become as interested in the private lives of its athletes as in their athletic performances.
- Federal, state, and local government officials will determine a prioritization schedule for how to allocate the initially limited vaccine doses to specific population groups. Federal agencies asked the National Academies of Medicine (NAM) to develop a framework for prioritization, which NAM released on October 2. The NAM findings will inform additional recommendations and policies to be developed by the CDC’s Advisory Committee on Immunization Practices (ACIP), the official federal advisory committee that informs CDC’s immunization policies, practices, and recommendations. The NAM framework and initial discussions at ACIP indicate that high-risk workers in health care facilities, first responders, and persons at elevated risk from COVID-19 disease such as the elderly, are likely to be among the groups prioritized for receipt of the early, limited number of vaccine doses.
- In addition to the overall ranking, US News also offers region-, country- and subject-specific rankings, to allow for more tailored searching.
Despite the huge production, the focus was on the 40 gorgeous models who walked the runway.
In this post, we’ll take a look at 16 software applications that I use almost every day — and discuss why you should too.
A total of 13.14 million new urban jobs were added.
哈佛大学著名教授格雷厄姆?阿利森(Graham Allison)也警告说，东亚已走向“修昔底德陷阱”(Thucydides’s trap)，他并补充道：“当一个迅速崛起的大国与一个老牌霸权国竞争时，麻烦接踵而来。”2013年初，时任卢森堡首相的让-克洛德?容克(Jean-Claude Juncker)警告称，2013年看起来像1913年一样危险。2013年底，《经济学人》杂志(The Economist)也警告说，“一个世纪已过去，当今世界却与那个导致第一次世界大战爆发的时代有不少相似之处，令人不安。”
2. Do I have too much clutter? Drowning ourselves in too many material possessions can ultimately lead to stress. Get clear on what you absolutely need and what you can get rid of.
- While the U.S. military has been a key part of the OWS effort by supplying logistical, program management, and contracting expertise, current plans do not include a major role for the military in distributing Covid-19 vaccines to the general public.
Policy and Implementation Issues and Questions
The Datafolha poll was based on interviews with 693 fans at the Mineirao stadium in Belo Horizonte and had a statistical margin of error of 4 percentage points.
Selling that many cars would make Tesla larger than the U.S. arms of luxury makers like Lincoln and Porsche, both of which have more diverse product portfolios, long-established dealer networks, and refined strategies for marketing and advertising. Half the sales would come from the aging Model S sedan and the other half the new Model X seven-seat crossover that goes into production early next year.
Hurun founder Rupert Hoogewerf said Yao represented a new wave of wealthy Chinese, those whose money came from playing the financial markets as opposed to more traditional routes like trade or manufacturing.
The ranking is based on surveys of schools and alumni who graduated in2011. This edition gives a snapshot of alumni’s situation compared with when they started the programme.
The board is frequently covered in equations. Have you ever wondered what those equations mean? Well, we may never know what they mean, but they are all real, accurate equations. Very impressive, Big Bang. Very impressive indeed.
More importantly, their inventions may even eventually be turned into products that benefit mankind.
It had hit a record low of 48 in September, and was 49.9 in October.
And in the UK, could this be the year that the big consultancies make proper inroads into the legal market Will other “alternative business structures” — aka purveyors of “Tesco law” — finally gain a toehold at the consumer end by offering fixed-fee services, putting work out to tender to loose networks of lawyers, or cranking up the legal chatbot for instant, affordable advice Someone has to bust this sector open for the sake of the average citizen.
Han said on his social media that he only designed the original version of the mascot, which is the ink painting, but didn't participate in the 3D model design. "Of course we believe the ugly stuff has nothing to do with you," Web users said, responding to the respected artist.
Google's brand is now worth more than 109 billion U.S. dollars, around 2 billion dollars more than Apple, making it the most lucrative in the world.
A critical and potentially limiting factor in the distribution of a COVID-19 vaccine is resource constraints faced by state and local health departments, who will have the main responsibility for managing vaccine distribution. Public health has long been underfunded in the U.S., and the health and economic impacts of the pandemic have further strained state and local public health infrastructure and reduced state revenues upon which they depend. Many have yet to meet the testing and contact tracing needs they already face, let alone be ready to distribute a new vaccine. To date, Congress has appropriated approximately $2.45 billion across two of the four emergency COVID-19 relief bills2 to states, localities, and territories for a range of COVID-19 public health activities that, while not specific to vaccines, could include vaccine-related activities. Thus far, of these amounts, CDC has awarded $200 million from CARES Act funds to jurisdictions for vaccine preparedness, well below what is likely needed for such a large scale effort. At a September 16 hearing of the Senate Appropriations Subcommittee Hearing on Coronavirus Response, CDC Director Redfield stated that state and local jurisdictions needed $6 billion to support COVID-19 vaccine distribution, while the National Association of City and County Health Officers estimates the need at $8.4 billion. The Association of Immunization Managers, which represents the 64 state, local, and territorial immunization programs, has said that additional funds are needed for shoring up the health care workforce, opening new vaccine administration sites, adapting information systems, purchasing personal protective equipment, and combating disinformation and vaccine hesitancy, among other areas. Concerns about funding challenges have also been raised by the National Governors Association. Negotiations between Congress and the Administration on a fifth COVID-19 relief bill, which would have included billions for vaccine distribution (the House Democratic bill, the Heroes Act, included $7 billion and the Senate Republican bill included $6 billion), are stalled, so it is unclear when additional funding will be made available to states for this purpose.
Government-led vaccine distribution in the timeframe and at the scale being contemplated for COVID-19 has never before been done in the U.S., with hundreds of million doses needing to be distributed, over as short period of time as possible, in order to vaccinate most of the U.S. population. In contrast, in a typical year, CDC distributes about 75 million vaccine doses to health departments and private providers. In the context of the H1N1 pandemic during 2009-2010, the government distributed 124 million doses of the H1N1 pandemic influenza vaccine over the course of several months. In recent years, over 150 million doses of seasonal influenza vaccines have been delivered in the U.S. per year, though, as mentioned above, outside of the VCP and 317 programs, these vaccines are primarily distributed via the private sector, not by the government. In addition to the sheer number of doses likely to be needed, there are a host of logistical issues and supply challenges that come with the effort to distribute COVID-19 vaccines, including:
政府部门的数据显示，无论在销售额和销售量上看，今年上半年香港房地产销售较去年同期下降了近40%。香港差饷物业估价署(Rating and Valuation Department)本月发布的一项指数表明，商业地产受到的冲击尤为严重，今年5月价格较去年同期下降了5.7%。
Meanwhile, WeChat offers perhaps the greatest potential yet for Tencent to gain overseas users. Forrester analyst Bryan Wang said he has seen colleagues and friends in Singapore and India begin to appear on his WeChat contact list.
On Tuesday, 17-year-old Thomas Sohmers unveiled a new super fast computer server that uses a fraction of the electricity that a normal computer does.He's showing it off at the Open Compute Project (OCP) Summit happening this week in San Francisco.This computer is the first product from Sohmers' startup, REX Computing, created with 52-year-old co-founder and CTO Kurt Keville.
The hair creates a resemblance to the look of Michelle Pfeiffer, but Ms. Chastain gives it more of an edge. Kay Georgiou, who frequently styles the hair of Matt Damon and Gwyneth Paltrow for films, oversaw the look.
Hitachi Data Systems
- Existing state and local governmental distribution networks are primarily focused on delivering childhood, but not adult vaccines. Especially early on, adults will likely be the focus for COVID-19 vaccine distribution, and mass distribution of vaccines to adults has, in the past, proven more challenging than delivering to children. This is because there are fewer pre-existing relationships and networks through state and local governments for adult vaccinations. During 2009-2010, for example, state and local vaccine programs had to triple the number of providers they had a relationship with to be able to distribute 2009-H1N1 vaccines. Governments at all levels will likely have to significantly expand their distribution channels and partnerships for vaccine administration to reach target groups with a COVID-19 vaccine.
- There will be a need to account for flexibility in planning and implementation of distribution. As the CDC and HHS plan distribution plans already recognize, there will be few doses available early on in the distribution process, with the supply of vaccine extremely limited compared to the demand. This will mean the first doses will be rationed, and that roll out will occur with unpredictable timing, as vaccine doses become available as production expands. Therefore, it will be important to set realistic expectations on initial supply. The effort to roll-out the 2009 H1N1 pandemic influenza vaccine lost credibility among state and local officials and the public alike when the amount of vaccine available to the public in October 2009 did not meet the earlier expectations that had been set by federal officials.
- Several of the likely COVID-19 vaccine candidates need to be preserved at extremely cold temperatures, which will require specialized equipment not currently available in many distribution sites. Urban areas, where specialized equipment is more likely to be present, will likely be able to manage cold chain supply processes more easily than rural areas where the equipment may not be available, which could introduce inequities in distribution. The federal government has stated it would likely not require jurisdictions to procure additional equipment but could implement a distribution approach that involved distributed networks of federally managed cold chain sites and use of mass vaccination to reach target populations.
- Several leading vaccine candidates will require two doses for immunization, with the second dose given several weeks after the first, which raises additional challenges. Vaccines with two-dose regimens will require careful tracking of doses and follow up with each individual receiving the vaccine to ensure they receive the same vaccine, with the second dose given at the proper time. This kind of two-dose schedule has not been required for other mass-distributed vaccines such as seasonal influenza or during the 2009-H1N1 pandemic influenza. The CDC and local jurisdictions are in the process of implementing a new vaccine tracking system to monitor COVID-19 vaccine administration and help with multiple dose tracking, but it is unclear if, or how, the new system will integrate with 家居产品召回制度 离我们还有多远？ (IIS). There is already great variation in IIS across jurisdictions, and many have gaps and face other challenges including low provider participation rates and lack of interoperability of immunization records with patients’ electronic health records and across jurisdictional borders.
- Vaccines may be released on an accelerated schedule, and some may be administered under an EUA without having gone through a full safety review initially, so the government is planning on implementing enhanced safety monitoring to track vaccine adverse events. Close tracking of safety and adverse events is yet another layer of planning and administration falling primarily on state and local health authorities. Tracking adverse events closely will be important not only to determine the safety of the vaccines, but also to establish evidence of harm in individuals for potential compensation purposes. Under the liability protections outlined in the Public Readiness and Emergency Preparedness (PREP) Act manufacturers cannot be held liable for damages caused by their vaccines (except where there has been willful misconduct). However, individuals who die or suffer serious injuries directly caused by the administration of an approved vaccine under conditions of a public health emergency could receive compensation from the government through the 被约谈的“互联网+中介”真有本事垄断市场、推高房租吗？ (CICF), although there are some limitations to the CICF.
Bored with your day-to-day life? It’s time to go on an adventure and refresh yourself! The Antarctic is undoubtedly a good choice. Watching native penguins playing and seeing millions of seabirds flying across the sky is much more exciting than watching TV documentaries. Imagine how cool and fascinating it is to be in a world of majestic icebergs and unexplored mountain ranges. But remember, it’s a polar region, so prepare well before you set off. Insulated boots, warm coats, gloves, wool socks and hats are a must.
There remain outstanding issues concerning the relative roles and responsibilities of the federal, state and local governments in distributing a vaccine, as well as those of private actors. While much of the responsibility in the U.S. for delivering public health services, including support for vaccination, lies at the state and local levels, other considerations may be warranted in the midst of a pandemic that has been declared a national emergency. Federalism has benefits for public health, particularly the ability to localize responses, but raises unique challenges in a pandemic, with the potential for a complicated patchwork of different rules and regulations to navigate across jurisdictions, which could result in different timetables for receiving and shipping vaccines to providers, different levels of success in reaching target outcomes across the country, and differential access by geography, which could exacerbate existing inequalities in access and care and ultimately have implications for public health and broader population immunity. As one example, adult coverage rates for seasonal influenza, an ACIP-recommended vaccine that is free for most with insurance, vary by state, ranging from a low of 25% in Nevada to a high of 51% in Rhode Island (among those ages 18-64).
It’s been one of the worst years for investment decision-making on record, almost across the board. No strategy worked consistently, save for the type of shareholder activism that only a handful of Wall Street’s billionaire titans are able to engage in.
- Vaccine mandates: Governmental vaccine mandates play a role in the distribution and uptake of many vaccines, but the extent to which mandates can and will be used by federal, state, and local authorities to encourage COVID-19 vaccinations remains an open question. There are potential mechanisms by which federal authority could impose vaccine requirements such as though conditioning some forms of federal funding on vaccination, but there is a debate about how far federal powers extend here and whether the government should use these authorities for COVID-19 vaccines. On the other hand, state and local jurisdictions commonly impose vaccine mandates and could use their authorities to impose COVID-19 vaccination mandates, but this might mean requirements would vary greatly across jurisdictions.
What Separates Wolves From Dogs
- Seasonal influenza vaccinations are typically not mandated by states, though some have taken steps toward such mandates. In August, Massachusetts announced it would require children in daycares and schools to receive a seasonal influenza vaccination this year; other states could follow. In 2009-2010 there were no state-level mandates requiring that children or adults receive a 2009-H1N1 influenza vaccine.
- Some states also mandate vaccines for certain types of health care workers, such as those working in hospitals or long-term care facilities. State laws vary considerably in terms of which vaccines are required, which types of workers the mandates cover, and what types of exemptions from these mandates are allowed. In the future, similar mandates could be developed by states for COVID-19 vaccines.
- States have additional authorities to mandate vaccinations during public health emergencies and outbreaks, often with 地产圈新花样 盘点“互联网＋”下的新式营销 resting with the governor of the state or with a state health officer. For example, following a measles outbreak in 2019, New York City declared a public health emergency and used its expanded authority to requirethat individuals in certain zip codes to be vaccinated for measles. The differential application of these expanded authorities by states could introduce further inequities in vaccine coverage.
- Finally, in some cases, the private sector may mandate vaccination as a condition of employment, such as a hospital mandating vaccination for its health care workers. More generally, the U.S. Occupational Safety and Health Administration (OSHA) has taken the position that employers can require employees to be vaccinated for influenza, though exemptions may be provided. The U.S. Equal Employment Opportunity Commission (EEOC) states that employers should consider encouraging, rather than requiring, vaccination and, if vaccination is required, employees may be entitled to exemptions. Given the gravity of COVID-19, it is possible that employers will seek to mandate vaccination in some cases.
|Table 3: State Mandates for ACIP-Recommended Pediatric Vaccines|
|Vaccine||Number of States with Mandate|
|DTaP/Tdap||50 states and DC|
|MMR||50 states and DC**|
|Polio||50 states and DC|
|Chicken pox||50 states and DC|
|Hepatitis A||17 states and DC|
|Hepatitis B||46 states and DC|
|HPV||3 states and DC|
|Meningococcal||29 states and DC|
NOTES: DTaP/Tdap: tetanus, diphtheria, and pertussis; MMR: measles, mumps, rubella; HPV: human papillomavirus
*CT, NJ, PA, and RI only require annual flu shots in childcare settings; MA requires of all children.
**IA does not require a mumps vaccine
SOURCE: KFF analysis of Information from state statutes and immunization websites.
- Scope of practice regulations for vaccine administration. A key issue to consider concerns regulations around who can administer vaccines. Licensing of providers who can administer vaccines is determined at the state level, and therefore varies across the country. Expanding this scope of practice is one avenue for increasing distribution channels and uptake. Medical providers, such as physicians and nurses, commonly administer vaccines, but pharmacists can also administer many vaccines. State requirements around pharmacist administration of vaccines vary, particularly around which vaccines can be administered, what kind of training is needed to be licensed, and what for what ages pharmacists can vaccinate. During a public health emergency states can expand scope of practice laws, as several states did during the H1N1 pandemic in 2009-2010, but this can lead to differences across states. During a public health emergency, the federal government also has authority to expand scope of practice regulations under the PREP Act, and HHS has already done so to authorize pharmacists 北京“限竞房” 打起价格战 同质化造成选择困难 vaccines to individuals ages three through 18 years and 国家政策扶持 智能家居再迎发展契机 when they become available. The COVID-19 vaccine authorization specifically preempts any state or local law that would prohibit these providers from administering vaccines, if the providers satisfy the requirements laid out in the guidance. States, and the federal government, could consider further expansions of scope of practice to accommodate the scale of COVID-19 vaccination requirements, if needed.
Ensuring that COVID-19 vaccines are available at no-cost to individuals would greatly enhance access. Both the Administration and Congress have taken steps to address this issue. The OWS strategy states that the Administration’s advance purchase of millions of doses of COVID-19 vaccines candidates from multiple manufacturers is intended to ensure that no American will be charged for the vaccine or its administration (although it is possible that some vaccine providers may still charge an administration fee). The Families First Coronavirus Response Act and the CARES Act put specific requirements in place for no-cost COVID-19 vaccine access under private insurance, Medicaid, and Medicare. These build on existing protections provided under the Affordable Care Act (ACA). However, despite these measures, limitations and gaps related to a COVID-19 vaccine remain, and some individuals, particularly adults, may still face cost and access barriers. Some of the key provisions and outstanding issues include:
- Private Insurance: Under federal legislation, most private insurers will be required to cover COVID-19 vaccines at no-cost. The ACA requires private health insurers to cover any vaccine recommended by ACIP at no-cost, although insurers have up to one year from the time of recommendation to implement coverage. The CARES Act specifically requires group health plans and health insurance issuers (those subject to ACA requirements for preventive services, but not including short-term limited duration or association health plans) to cover any ACIP-recommended COVID-19 vaccine without cost-sharing, including the cost of administration. Such coverage must begin 15 business days after an ACIP recommendation, which eliminates the usual up to one-year timeframe. However, these cost protections are not necessarily available if a patient seeks a vaccine from an out-of-network provider.
- Medicaid. All children and some adults in Medicaid have coverage for vaccines at no cost, and Congress has temporarily addressed the gap for other adults to ensure coverage for a COVID-19 vaccine. The ACA requires Medicaid coverage of all ACIP-recommended vaccines at no-cost for adults in the Medicaid expansion population. However, for adults covered through traditional Medicaid pathways, immunizations are an optional Medicaid benefit and, when covered, cost-sharing may be imposed. Currently, less than half of states cover all ACIP-recommended adult immunizations. The Families First Act addressed this by 女子名下突然多9套房涉千万 此前曾出借身份证 in federal Medicaid matching funds to help states respond to COVID. As a condition of receiving these enhanced funds, states must cover COVID-19 vaccines without cost-sharing, during the public health emergency. When the public health emergency declaration ends, however, adults in traditional Medicaid could face cost-sharing or may not have coverage for the vaccine. For children, Medicaid covers vaccines at no-cost through the Vaccines for Children Program (VCP), a 100% federally funded entitlement program created by Congress in 1993. The VCP also provides no-cost vaccine coverage for American Indian and Alaskan Native children, uninsured children, and children who meet the program’s criteria for being underinsured. In addition, the Children’s Health Insurance Program (CHIP) also provides vaccine coverage for its enrollees, uninsured children who have incomes above Medicaid eligibility levels.
- Medicare. Vaccines are covered through Medicare, but some beneficiaries may face cost-sharing or delayed access for a COVID-19 vaccine, depending on the process used by FDA to make a vaccine available for use. Medicare covers vaccines under Parts B and D, with most vaccines covered under Part D. Part D plans must cover all FDA-approved vaccines, although they may impose cost-sharing. The CARES Act requires Medicare Part B to cover a COVID-19 vaccine and its administration without cost-sharing upon licensure by the FDA; this applies to beneficiaries in both traditional Medicare and Medicare Advantage plans. It does not, however, require such coverage upon issuance of an EUA, which could limit access to vaccines for the more than 60 million people covered by Medicare if a vaccine first becomes available via an emergency authorization.
- Uninsured and underinsured adults: There is no federal entitlement vaccination program for uninsured and underinsured adults. Instead, existing federal programs that support vaccination for the uninsured and underinsured are discretionary and rely on annual Congressional appropriations for funding. These include 雷士照明内乱背后的“合伙人困境”, which authorizes the federal purchase of vaccines for uninsured or underinsured adults (as well as children and adolescents), and can be used during an outbreak, and funding for FQHCs, which provide vaccinations regardless of ability to pay. During H1N1, the federal government 加大老旧电梯更新改造力度 提高电梯安全节能环保水平 to ensure that uninsured and underinsured adults received it free of charge, as long as they were vaccinated at a public health clinic or other designated site. Similarly, it is expected that the federal government’s purchase of COVID-19 vaccines will be used to support free vaccination of adults who are uninsured and underinsured. Funds to providers to cover vaccine administration costs will be available through a “多措并举促进我国社区养老和家政服务业进一步加快发展”, part of a new Provider Relief Fund created and funded through the CARES Act and the Paycheck Protection Program and Health Care Enhancement Act. Despite these measures, it is not yet known if the existing advance purchase of COVID-19 vaccines or the claims reimbursement program will be sufficient to support vaccination for all those who are uninsured and underinsured, and whether additional funding or other remedies might be needed.
COVID-19 has had a significant impact on communities of color in the U.S., who account for a disproportionate share of COVID-19 cases, hospitalizations, and deaths. Data also indicate that the pandemic is taking a larger economic toll on communities of color, and that COVID-19 threatens to further widen racial and ethnic disparities that already exist in the U.S. Moreover, the medical system’s historic mistreatment of people of color and ongoing racism and discrimination contribute to greater distrust among communities of color that may contribute to increased reluctance to be vaccinated. A new KFF/The Undefeated survey, for example, found that half of Black adults say they would not want to get a coronavirus vaccine even if deemed safe by scientists and freely available, with safety concerns and distrust cited as the top reasons (see Figure 1). By contrast, most White adults say they would get vaccinated, and those who wouldn’t are more likely to say they don’t think they need it. In addition, the survey found that majorities of Black adults lack confidence that the vaccine development process is taking the needs of Black people into account, and that when a vaccine becomes available it will have been properly tested and will be distributed fairly. Already, there are significant disparities in adult vaccine coverage rates for racial and ethnic minorities in the context of routine immunization. For example, coverage rates for seasonal influenza, which is available at no-cost to those with insurance, are lower for adults of color compared to Whites. Coverage rates by race/ethnicity also vary by state. Taken together, these issues present formidable challenges not only to reaching people of color with a COVID-19 vaccine, but to the success of the overall national COVID-19 vaccine effort. Ultimately, effective outreach strategies developed in partnership with and directed toward communities of color will be critical to building public trust and willingness to get vaccinated.
Bangkok is projected to host 21.47 million "international overnight visitors" this year, according to the 2016 report by financial services corporation MasterCard.
AdWords puts advertising higher up Google's search results and on other websites. The advertiser only pays when someone clicks on one of these links.
开发商：Dontnod Entertainment、Square Enix
From Yahoo’s bombshell announcement of a data breach that affected millions, to the recent WannaCry and BadRabbit ransomware attacks, 2017 has brought several major cybersecurity disasters.
Net interest margins — the difference between interest paid on deposits and interest gained from loans — suffered as China lifted its remaining controls on the interest rates paid on deposits. The average margin declined by about 46 basis points to 2.54 per cent in 2015.
This umbrella protects your dogs from the sun and rain.
The media mogul is accused of blacklisting the actress after the meeting as well as deploying former Mossad agents to follow her and steal her memoir's manuscript.
We will ensure workplace safety and people's lives.
- You're right to be paranoid. The company is always watching you, and there's a record of everything you do: every phone call, every text, every tweet and instant message. At most companies, they save that data forever.
John Stevenage, chief executive of British Mensa, said he was delighted for Nishi. He said: 'I hope she will make full use of her membership to meet new, like-minded people and challenge herself. Joining Mensa opens the door to an international network of more than 100,000 people and many members make friends for life.
The annual rich list of China's movers and shakers gives a temperature check on where money is flowing in China, and underlines the growing financial muscle of the country's super-rich.
- Polling on COVID-19 vaccines has indicated an increasing level of mistrust about the vaccines and decreasing willingness among Americans to receive one. In May, 72 percent of U.S. adults said they would definitely or probably get a vaccine to prevent COVID-19 if it were available but in September only 51 percent said the same (a 21 percent decline in four months). Partially driving this growing distrust among Americans is an increasing concern with politicization of the vaccine approval process: a majority of the public (62 percent) is worried 2016年LED行业整合洗牌加剧 企业如何在竞争中赢得未来？ to approve a coronavirus vaccine without making sure that it is safe and effective. As noted above, Black adults in particular have expressed some of the highest levels of mistrust of COVID-19 vaccines even as this group has been disproportionately affected by the pandemic.
- Reducing mistrust about COVID-19 vaccines would involve a 南京江宁楼盘朗诗玲珑郡被曝“偷面积”, including efforts to counter the growing public perception that politics is driving the vaccine approval process for COVID-19 to ensure Americans have confidence that when a vaccine is approved that they believe it is indeed safe and effective. A recent letter from the HHS National Vaccine Advisory Committee to the Assistant Secretary for Health included recommendations for building public confidence, including through a unified, proactive, and highly visible, communication structure and community and stakeholder engagement. Transparency and avoiding conflicts of interest helps in reducing mistrust. In addition, having clear, consistent, and culturally-relevant messages about COVID-19 vaccines and their benefits to individuals, communities, and the country will be important, as will building partnerships in advance with individuals and groups that can serve as trusted sources for delivering such messages for different communities. Given that safety of vaccines has been the number one concern both in past vaccination campaigns and regarding COVID-19 vaccines, a particular emphasis on assuring safety will be important.
Though Hand was British Petroleum's SVP of Global Brand, Marketing and Innovation, for several years, she's on a much more environmentally friendly mission today. Project Frog aims to revamp the construction industry with simple-to-build spaces (they takes days, rather than months to construct) that consume about 50% less energy than traditional buildings for sectors like education and healthcare. Hand's plan seems to be working: revenue is expected to more than double this year.
The report by iResearch Consulting Group and Sina Weibo, China's most popular microblogging platform, was released at a forum in Shanghai, co-organized by Weibo and telecom giant Huawei .
Many technicians think that during the course of this century computerized robots might compete and win against humans.
I do not see much evidence that radical “managerless” models such as “Holacracy” will catch on. But more companies will realise that if they constantly test innovative ways forward — as start-ups do — they will be more flexible and decisive than old-style bureaucracies and meritocracies.
How are your competitors getting found online? Google Adwords Keyword Planner helps you answer this question. The word “Adwords” may give some ‘treps pause, as it sounds like you will have to purchase advertising. Not true. Google has made its Keyword Planner tool available to anyone with a Google account (you must first click through the Adwords entry portal). Use the Adwords Keyword Planner to see what keywords are generating the most search volume in your niche and identify opportunities to capture traffic.
Five schools from five different countries are ranked for the first time. Singapore’s Lee Kong Chian School of Business is the highest new entrant coming straight into 36th place. Canada’s Queen’s Smith School of Business registered the best progression, climbing 32 places to 67th.
Taylor Swift and Katy Perry opted for bedazzled5 dresses in very different styles. Taylor went for a more old Hollywood, glamorous Grecian style that exposed her back and statuesque6 figure, while Katy rocked a shorter, spunkier look that exposed a little of everything.
Metals cases made up a record 46 per cent of the 233 anti-dumping actions brought worldwide in 2015, with the steel industry accounting for almost all of the metals complaints.
The country's improved performance has notched the 17th place in "innovation quality", an indicator that looks at the caliber of universities, number of scientific publications and international patent filings.